In this two-part episode of #DrugSafetyMatters, we're joined by Niklas Norén to discuss how #AI can add value to #pharmacovigilance and how a risk-based approach to its regulation can help maintain human oversight throughout the PV cycle.

🎧 Tune in to Part 1 to learn more 👉 ow.ly/iRPq50Xq0xP

#MedicationErrors are a leading cause of avoidable harm in healthcare, affecting millions of people worldwide each year.

By understanding the different types of errors and finding effective ways to prevent them, we can improve the safety of medicines for everyone ✅

Learn more 👉 ow.ly/F4q150W5qYF

💊 Monitoring the safety of medicines doesn’t stop once they hit the pharmacy shelves.

Whether you're a patient, healthcare professional, regulatory, or company, we all have the power to make medicines safer – #ReportSideEffects ✅

Learn more about the #MedSafetyWeek cause 👉 ow.ly/XEoc50LlhaJ

Do you know how to be a #MedSafetyHero? 💪

One of the key sources of information for suspected side effects to medicines is you, the patient. No matter how mild or how severe, don't wait – #ReportSideEffects and help make medicines safer.

Read up on #MedSafetyWeek 👉 ow.ly/XEoc50LlhaJ

We all have the power to be a #MedSafetyHero 💪

Reporting side effects helps regulatory agencies understand more about the safety profile of medicines.

Help keep others safe from future harm – #ReportSideEffects.

🔊 Join the #MedSafetyWeek cause 👉 ow.ly/XEoc50LlhaJ

Medicines can affect our personality in positive ways, but they may also lead to destructive behaviours. Listen to #DrugSafetyMatters with Michele Fusaroli to learn more about how to diagnose and treat drug-induced impulse control disorders. 
 
🎧 Tune in 👉 ow.ly/QMHR50RuLhn

Medication-related harm is especially prevalent in older adults due to changing physiology, increased frailty, and incidence of #polypharmacy.

Giovanni Furlan discusses #pharmacovigilance in older adults on the #DrugSafetyMatters podcast.

Listen now 🎧 ow.ly/vEeV50U67GU

#OlderPersonsDay